"Encouraged by the success of checkpoint inhibitors in fighting some cancers, many companies are developing antibodies that block the LAG-3-MHC-II interaction, including Tesaro(TSR033), Novartis (LAG525), Bristol-Myers Squibb (relatlimab) and F-star (FS118). The safety and efficacy of these candidate immunotherapies are being evaluated in trials for several advanced cancers."
Soooo....could someone with a better understanding of the science than I, please explain if our little Efti has been on the right track?
Thanks in advance.
"Encouraged by the success of checkpoint inhibitors in fighting...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $913.3K | 3.099M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 124895 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 30287 | 2 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
